As the curtains opens on 2026, FoodCo, a Top-5 Nigerian retailer with interests in supermarkets, quick service restaurants, ...
First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...
Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback